Antimicrobial Peptides Market - Global Forecast 2025-2030

The antimicrobial peptides market is rapidly evolving, driven by ongoing innovation in therapeutic development and heightened demand for alternatives to traditional antibiotics. Senior decision-makers require reliable, actionable insights to navigate this dynamic landscape and secure competitive advantages.

Market Snapshot: Antimicrobial Peptides Market Growth and Trends

The antimicrobial peptides market grew from USD 1.05 billion in 2024 to USD 1.15 billion in 2025. With a projected CAGR of 10.44%, the market is expected to reach USD 1.90 billion by 2030. This surge is underpinned by increasing demand for new therapeutics to address multidrug resistance, emerging technological advancements in peptide design and synthesis, and expanding applications across healthcare, agriculture, food, and cosmetics sectors.

Scope & Segmentation of the Antimicrobial Peptides Market

The report delivers a comprehensive analysis of the antimicrobial peptides ecosystem, highlighting prominent market drivers and barriers. It covers developments across industry leaders, regional growth patterns, and the latest advancements in peptide technology. Segmentation includes multiple facets:

Source: Animal, Microbial, Plant, Synthetic.
Structure: Alpha-helical, Beta-sheet, Loop.
Mechanism of Action: Intracellular Targeting, Membrane Pore Formation.
Application: Agriculture, Cosmetics, Food, Pharmaceuticals including Antibacterial, Anticancer, Antifungal, Antiviral, Immunomodulation, and Wound Healing.
Region: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa, and others), and Asia-Pacific (notably China, India, Japan, Australia, and additional regional leaders).
Key Companies: AbbVie Inc., Alexion Pharmaceuticals, Amferia AB, AstraZeneca plc, Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Merck KGaA, Novartis AG, Pfizer Inc., Vertex Pharmaceuticals, and others positioned within discovery, manufacturing, and commercialization.

Emerging production technologies, such as solid-phase synthesis and recombinant platforms, are enabling enhanced scalability and cost-efficiency, while regional research networks and regulatory frameworks shape local adoption.

Key Takeaways for Decision-Makers

Antimicrobial peptides demonstrate broad-spectrum applications, extending well beyond pharmaceuticals into agriculture, food safety, and cosmetics.
Strategic partnerships between biotechnology firms, academic consortia, and contract development organizations are vital for accelerating candidate optimization and technology transfer.
Bioinformatics and machine learning are transforming peptide discovery, markedly reducing lead times and supporting rational drug design for improved activity and safety profiles.
Novel delivery systems—including nanoparticles and hydrogels—are expanding administration options, addressing stability and bioavailability limitations that historically hindered clinical adoption.
Companies focusing on application-specific alignments, such as antimicrobial coatings or advanced wound care, are reinforcing their market position through targeted vertical integration and intellectual property strategies.

Tariff Impact: United States Market Dynamics in 2025

Recent United States tariffs introduced in 2025 are prompting strategic reassessments of supply chain models and sourcing agreements. Market players are actively investing in domestic manufacturing, negotiating long-term contracts, and exploring alternative global partnerships to reduce exposure to fluctuating import costs. These adaptations require upfront investment but have catalyzed process innovation and increased supply chain resilience.

Methodology & Data Sources

This report synthesizes primary interviews with industry leaders and subject experts alongside rigorous secondary research, including peer-reviewed journals, regulatory filings, patents, and company disclosures. Triangulation of qualitative and quantitative data ensures robust, validated insights reflective of real-world trends and market forces.

Why This Antimicrobial Peptides Market Report Matters

Enables senior leaders to anticipate shifts in therapeutic strategies and global supply chains, empowering more resilient business decisions.
Provides an actionable framework for technology benchmarking, partnership alignment, and regulatory planning at both macro and operational levels.
Facilitates targeted investments with a clear understanding of regional strengths, innovation ecosystems, and evolving end market demands.

Conclusion

The antimicrobial peptides market is progressing rapidly, fueled by innovation, strategic alliances, and evolving regulatory conditions. Industry stakeholders leveraging these insights will be best positioned to capture growth opportunities and drive advancements in health and commercial value.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Novel lipidated antimicrobial peptides demonstrating enhanced efficacy against multi-drug-resistant Gram-negative bacteria
5.2. Implementation of AI-driven de novo peptide design platforms for rapid identification of potent antimicrobial sequences
5.3. Development of peptide-based biofilm-disrupting formulations to prevent chronic wound infections
5.4. Integration of peptide-conjugated nanocarriers for targeted delivery and reduced peptide degradation in systemic infections
5.5. Progress in microbiome-friendly antimicrobial peptides minimizing dysbiosis in gastrointestinal therapeutic applications
5.6. Emergence of collaborative partnerships between biotech startups and pharmaceutical companies to accelerate AMP clinical trials
5.7. Regulatory frameworks evolving to address safety and standardization of synthetic antimicrobial peptides in medical devices

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Antimicrobial Peptides Market, by Source

8.1. Introduction
8.2. Natural
8.2.1. Animal
8.2.2. Microbial
8.2.3. Plant
8.3. Synthetic

9. Antimicrobial Peptides Market, by Structure

9.1. Introduction
9.2. Alpha-helical
9.3. Beta-sheet
9.4. Loop

10. Antimicrobial Peptides Market, by Mechanism of Action

10.1. Introduction
10.2. Intracellular Targeting
10.3. Membrane Pore Formation

11. Antimicrobial Peptides Market, by Application

11.1. Introduction
11.2. Agriculture
11.3. Cosmetics
11.4. Food
11.5. Pharmaceuticals
11.5.1. Antibacterial
11.5.2. Anticancer
11.5.3. Antifungal
11.5.4. Antiviral
11.5.5. Immunomodulation
11.5.6. Wound healing

12. Americas Antimicrobial Peptides Market

12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina

13. Europe, Middle East & Africa Antimicrobial Peptides Market

13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland

14. Asia-Pacific Antimicrobial Peptides Market

14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan

15. Competitive Landscape

15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Alexion Pharmaceuticals, Inc.
15.3.3. Amferia AB
15.3.4. AnaSpec Inc.
15.3.5. AstraZeneca plc
15.3.6. Bayer AG
15.3.7. Boehringer Ingelheim International GmbH
15.3.8. Celdara Medical, LLC
15.3.9. Eli Lilly and Company
15.3.10. EnBiotix Inc.
15.3.11. Hello Bio
15.3.12. Ingenza Limited
15.3.13. Johnson & Johnson Services, Inc.
15.3.14. Magainin Pharmaceuticals, Inc.
15.3.15. Matrubials Inc.
15.3.16. MaxWell Biosciences
15.3.17. Meddenovo Drug Design
15.3.18. Melinta Therapeutics
15.3.19. Merck KGaA
15.3.20. Novartis AG
15.3.21. Novo Nordisk A/S
15.3.22. Nuritas Ltd.
15.3.23. Peptilogics
15.3.24. Pfizer Inc.
15.3.25. Toagosei Co Ltd
15.3.26. Vertex Pharmaceuticals Incorporated

16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix

List of Figures

FIGURE 1. ANTIMICROBIAL PEPTIDES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANTIMICROBIAL PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANTIMICROBIAL PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANTIMICROBIAL PEPTIDES MARKET: RESEARCHAI
FIGURE 24. ANTIMICROBIAL PEPTIDES MARKET: RESEARCHSTATISTICS
FIGURE 25. ANTIMICROBIAL PEPTIDES MARKET: RESEARCHCONTACTS
FIGURE 26. ANTIMICROBIAL PEPTIDES MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. ANTIMICROBIAL PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ALPHA-HELICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ALPHA-HELICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY BETA-SHEET, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY BETA-SHEET, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY INTRACELLULAR TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY INTRACELLULAR TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MEMBRANE PORE FORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MEMBRANE PORE FORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY FOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY FOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTICANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTICANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY ANTIVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 166. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 167. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 169. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 170. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 171. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 174. GERMANY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 178. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 179. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 181. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 182. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 183. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 186. FRANCE ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 199. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 200. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 201. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 202. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 203. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 204. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 205. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 206. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 207. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 210. ITALY ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 214. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 215. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 217. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 218. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 219. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 222. SPAIN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 262. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 263. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 265. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 266. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 267. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 270. DENMARK ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 283. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 284. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 285. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 286. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 287. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 288. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 289. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 290. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 291. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 294. QATAR ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 298. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 299. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 300. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 301. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 302. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 303. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 306. FINLAND ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA ANTIMICROBIAL PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 331. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 333. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 334. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 335. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
TABLE 336. EGYPT ANTIMICROBIAL PEPTIDES MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
TABLE 337. EGYPT ANTIMICROB

Samples

LOADING...

Companies Mentioned

The companies profiled in this Antimicrobial Peptides market report include:

AbbVie Inc.
Alexion Pharmaceuticals, Inc.
Amferia AB
AnaSpec Inc.
AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
Celdara Medical, LLC
Eli Lilly and Company
EnBiotix Inc.
Hello Bio
Ingenza Limited
Johnson & Johnson Services, Inc.
Magainin Pharmaceuticals, Inc.
Matrubials Inc.
MaxWell Biosciences
Meddenovo Drug Design
Melinta Therapeutics
Merck KGaA
Novartis AG
Novo Nordisk A/S
Nuritas Ltd.
Peptilogics
Pfizer Inc.
Toagosei Co Ltd
Vertex Pharmaceuticals Incorporated

Table Information

Report Attribute	Details
No. of Pages	199
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 1.15 billion
Forecasted Market Value ( USD ) by 2030	$ 1.9 billion
Compound Annual Growth Rate	10.4%
Regions Covered	Global
No. of Companies Mentioned	27

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3144EUR$3,545USD£2,727GBP €3494EUR$3,939USD£3,030GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3392EUR$3,824USD£2,942GBP €3769EUR$4,249USD£3,269GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4597EUR$5,183USD£3,987GBP €5108EUR$5,759USD£4,430GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5563EUR$6,272USD£4,825GBP €6181EUR$6,969USD£5,361GBP

Market Snapshot: Antimicrobial Peptides Market Growth and Trends

Scope & Segmentation of the Antimicrobial Peptides Market

Key Takeaways for Decision-Makers

Tariff Impact: United States Market Dynamics in 2025

Methodology & Data Sources

Why This Antimicrobial Peptides Market Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Antimicrobial Peptides - Global Strategic Business Report

Antimicrobial Peptides Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Green Antimicrobial Market - Global Forecast 2025-2030

Spleen Aminopeptide Oral Lyophilized Powder Market - Global Forecast 2025-2030

2025 Lupine Peptides Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)